And the winners are…

The breadth and depth of Northeastern’s research and entre­pre­neurial spirit was on full dis­play Thursday at RISE:2016, the university’s Research, Inno­va­tion, and Schol­ar­ship Expo. Industry leaders judged some 400 projects, which detailed the work of more than 900 North­eastern stu­dents and fac­ulty. The judges sub­mitted their rat­ings and the top award win­ners were rec­og­nized at an after­noon recep­tion in East Village.

Good things come in small packages

Pic­ture this: A sensor the size of two match­sticks side-​​by-​​side that can detect a bac­te­rial infec­tion in two min­utes flat. It would quickly enable health-​​care providers to admin­ister an antibi­otic that tar­gets the spe­cific bug rather than a broad-​​spectrum drug that could be hit-​​or-​​miss. That describes the mind-​​boggling research project that Daniel Ost­berg, E’20, dis­played in Inno­va­tion Alley at RISE:2016.

What social media data could tell us about the future

Can a flow of infor­ma­tion across Twitter signal when a momen­tous event is about to occur? Northeastern’s Alessandro Vespig­nani and an inter­dis­ci­pli­nary group of sci­en­tists devel­oped a method to find out. Their find­ings rep­re­sent an ini­tial step in con­structing models to detect trouble before it’s too late.

3Qs: Is there a media bias in terrorist attack coverage?

In the past sev­eral months, ter­rorist attacks have rocked cities around the world. Many people have crit­i­cized the Western media’s cov­erage of the attacks as being uneven for con­cen­trating largely on the strikes in Euro­pean cities. We spoke with John Wihbey, assis­tant pro­fessor of jour­nalism and new media at North­eastern, about what he refers to as per­ceived “dif­fer­en­tial treat­ment” by main­stream news outlets.

Researchers investigate four promising new treatments for Lyme disease

North­eastern researcher Kim Lewis and his team have launched an all-​​out effort to find a cure for Lyme dis­ease, which afflicts nearly 300,000 new people in the U.S. each year. Their efforts aim to bring relief to all patients, including those who suffer from a debil­i­tating chronic ver­sion of the disease.